Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
Portfolio Pulse from Lara Goldstein
The article discusses various aspects of the psychedelics industry, including the potential of psychedelic treatments for PTSD in veterans, a possible $100M IPO by a psychedelics company, and Cybin Inc.'s new $64M offering. It also covers worldwide events related to psychedelics and provides a performance overview of the AdvisorShares Psychedelics ETF (PSIL) and several psychedelics stocks. Cybin Inc. announced an underwritten offering of units at $0.45, with $30M fully funded upon closing and an additional $34M upon full exercise of warrants. The article also lists the closing prices of several psychedelics stocks on November 10, with most showing a downward trend.
November 13, 2023 | 1:39 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
GH Research closed at $8.21, slightly down from the previous closing but maintaining an uptrend from earlier weeks.
While there's a slight decrease, the stock is still maintaining an uptrend from earlier weeks, indicating mixed signals.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
NEUTRAL IMPACT
Incannex Healthcare closed at $1.11, maintaining a slight upward trend from previous closings.
The stock's slight upward trend amidst a generally bearish sector could indicate resilience, but the impact is neutral short-term.
CONFIDENCE 70
IMPORTANCE 45
RELEVANCE 50
NEGATIVE IMPACT
Atai Life Sciences closed at $1.17, down from the previous week but showing mixed signals compared to earlier closings.
The stock's closing price is down, indicating a negative short-term impact, but it's not a clear trend due to mixed past performance.
CONFIDENCE 70
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
COMPASS Pathways closed at $5.27, a significant drop from the previous closing, aligning with a downward trend.
The marked descent in closing price suggests bearish investor sentiment and a negative short-term outlook.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 70
NEGATIVE IMPACT
Cybin Inc. announced a new underwritten offering of 66.66 million units at $0.45, with potential gross proceeds up to $64M. The stock closed at nearly $0.43, significantly down from previous closings.
The new offering could dilute existing shares, which typically puts downward pressure on the stock price. The closing price already reflects a negative sentiment.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Bright Minds Biosciences closed at $1.21, confirming a descending trend from previous closings.
The stock's continued decline suggests a bearish sentiment and a negative short-term impact.
CONFIDENCE 75
IMPORTANCE 55
RELEVANCE 60
NEGATIVE IMPACT
Enveric Biosciences closed at $1.58, showing a decline from previous weeks' closings, suggesting a negative trend.
The consistent drop in closing prices indicates a bearish outlook for the stock in the short term.
CONFIDENCE 75
IMPORTANCE 55
RELEVANCE 60
NEGATIVE IMPACT
FSD Pharma closed at $1.03, slightly down from the previous week, indicating a minor negative trend.
The stock's slight decrease in closing price suggests a potential short-term negative impact.
CONFIDENCE 65
IMPORTANCE 40
RELEVANCE 50
NEGATIVE IMPACT
Mind Medicine closed at $2.5, significantly lower than the previous week's high, indicating a bearish trend.
The considerable drop in closing price points to a negative short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 70
NEGATIVE IMPACT
AdvisorShares Psychedelics ETF opened at $1.5 but closed at $1.31, showing a decrease from previous weeks' closings. The ETF's yearly price range is now between $2.53 and $1.28.
The ETF's performance is indicative of the broader sector's challenges, and the closing price suggests a bearish outlook in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Silo Pharma closed at $1.36, down from the previous week, with a slight negative trend.
The stock's closing price is down from the previous week, indicating a potential short-term negative impact.
CONFIDENCE 70
IMPORTANCE 45
RELEVANCE 50